Az elso perkután aortabillentyu-beültetés Magyarországon

Géza Fontos, Zsolt Piróth, Sándor Szoke, Gábor Tóth, Dóra Vincze, Margit Szegedi, Krisztina Szüts, András Temesvári, Gabriella Hódi, László Székely, Luha Olev, P. Andréka

Research output: Article

1 Citation (Scopus)

Abstract

Aortic valve replacement can produce dramatic benefit in the setting of symptomatic aortic stenosis. The potential for morbidity and mortality associated with thoracotomy, cardiopulmonary bypass, and aortotomy has fostered a search for alternatives. Early experience with transcatheter endovascular aortic valve implantation demonstrated feasibility and efficacy, but the procedure was difficult to reproduce. However, equipment, techniques, and experience have evolved rapidly. Balloon-expandable and self-expanding prostheses and percutaneous femoral artery and open left ventricular apical access have found favor, each with potential advantages and disadvantages. Procedural success rates and clinical outcomes continue to improve. Current studies suggest that morbidity and mortality rates of percutaneous aortic valve implantations are much better in comparison to conventional surgery in selected high-risk patients. On November 11, 2008, in the Gottsegen György Hungarian Institute of Cardiology we performed the first two successful percutaneous aortic valve implantations in Central and Eastern Europe, following a more than one-year preparation period. After seven days the patients were discharged in very good conditions.

Original languageHungarian
Pages (from-to)387-396
Number of pages10
JournalOrvosi Hetilap
Volume150
Issue number9
DOIs
Publication statusPublished - márc. 1 2009

Fingerprint

Hungary
Aortic Valve
Morbidity
Eastern Europe
Mortality
Aortic Valve Stenosis
Thoracotomy
Femoral Artery
Cardiology
Cardiopulmonary Bypass
Prostheses and Implants
Equipment and Supplies

Keywords

  • Aortic stenosis
  • Percutaneous valve interventions
  • Valve disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fontos, G., Piróth, Z., Szoke, S., Tóth, G., Vincze, D., Szegedi, M., ... Andréka, P. (2009). Az elso perkután aortabillentyu-beültetés Magyarországon. Orvosi Hetilap, 150(9), 387-396. https://doi.org/10.1556/OH.2009.28563

Az elso perkután aortabillentyu-beültetés Magyarországon. / Fontos, Géza; Piróth, Zsolt; Szoke, Sándor; Tóth, Gábor; Vincze, Dóra; Szegedi, Margit; Szüts, Krisztina; Temesvári, András; Hódi, Gabriella; Székely, László; Olev, Luha; Andréka, P.

In: Orvosi Hetilap, Vol. 150, No. 9, 01.03.2009, p. 387-396.

Research output: Article

Fontos, G, Piróth, Z, Szoke, S, Tóth, G, Vincze, D, Szegedi, M, Szüts, K, Temesvári, A, Hódi, G, Székely, L, Olev, L & Andréka, P 2009, 'Az elso perkután aortabillentyu-beültetés Magyarországon', Orvosi Hetilap, vol. 150, no. 9, pp. 387-396. https://doi.org/10.1556/OH.2009.28563
Fontos G, Piróth Z, Szoke S, Tóth G, Vincze D, Szegedi M et al. Az elso perkután aortabillentyu-beültetés Magyarországon. Orvosi Hetilap. 2009 márc. 1;150(9):387-396. https://doi.org/10.1556/OH.2009.28563
Fontos, Géza ; Piróth, Zsolt ; Szoke, Sándor ; Tóth, Gábor ; Vincze, Dóra ; Szegedi, Margit ; Szüts, Krisztina ; Temesvári, András ; Hódi, Gabriella ; Székely, László ; Olev, Luha ; Andréka, P. / Az elso perkután aortabillentyu-beültetés Magyarországon. In: Orvosi Hetilap. 2009 ; Vol. 150, No. 9. pp. 387-396.
@article{c1072f6318a64465bdcf229b6cd41b1e,
title = "Az elso perkut{\'a}n aortabillentyu-be{\"u}ltet{\'e}s Magyarorsz{\'a}gon",
abstract = "Aortic valve replacement can produce dramatic benefit in the setting of symptomatic aortic stenosis. The potential for morbidity and mortality associated with thoracotomy, cardiopulmonary bypass, and aortotomy has fostered a search for alternatives. Early experience with transcatheter endovascular aortic valve implantation demonstrated feasibility and efficacy, but the procedure was difficult to reproduce. However, equipment, techniques, and experience have evolved rapidly. Balloon-expandable and self-expanding prostheses and percutaneous femoral artery and open left ventricular apical access have found favor, each with potential advantages and disadvantages. Procedural success rates and clinical outcomes continue to improve. Current studies suggest that morbidity and mortality rates of percutaneous aortic valve implantations are much better in comparison to conventional surgery in selected high-risk patients. On November 11, 2008, in the Gottsegen Gy{\"o}rgy Hungarian Institute of Cardiology we performed the first two successful percutaneous aortic valve implantations in Central and Eastern Europe, following a more than one-year preparation period. After seven days the patients were discharged in very good conditions.",
keywords = "Aortic stenosis, Percutaneous valve interventions, Valve disease",
author = "G{\'e}za Fontos and Zsolt Pir{\'o}th and S{\'a}ndor Szoke and G{\'a}bor T{\'o}th and D{\'o}ra Vincze and Margit Szegedi and Krisztina Sz{\"u}ts and Andr{\'a}s Temesv{\'a}ri and Gabriella H{\'o}di and L{\'a}szl{\'o} Sz{\'e}kely and Luha Olev and P. Andr{\'e}ka",
year = "2009",
month = "3",
day = "1",
doi = "10.1556/OH.2009.28563",
language = "Hungarian",
volume = "150",
pages = "387--396",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "9",

}

TY - JOUR

T1 - Az elso perkután aortabillentyu-beültetés Magyarországon

AU - Fontos, Géza

AU - Piróth, Zsolt

AU - Szoke, Sándor

AU - Tóth, Gábor

AU - Vincze, Dóra

AU - Szegedi, Margit

AU - Szüts, Krisztina

AU - Temesvári, András

AU - Hódi, Gabriella

AU - Székely, László

AU - Olev, Luha

AU - Andréka, P.

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Aortic valve replacement can produce dramatic benefit in the setting of symptomatic aortic stenosis. The potential for morbidity and mortality associated with thoracotomy, cardiopulmonary bypass, and aortotomy has fostered a search for alternatives. Early experience with transcatheter endovascular aortic valve implantation demonstrated feasibility and efficacy, but the procedure was difficult to reproduce. However, equipment, techniques, and experience have evolved rapidly. Balloon-expandable and self-expanding prostheses and percutaneous femoral artery and open left ventricular apical access have found favor, each with potential advantages and disadvantages. Procedural success rates and clinical outcomes continue to improve. Current studies suggest that morbidity and mortality rates of percutaneous aortic valve implantations are much better in comparison to conventional surgery in selected high-risk patients. On November 11, 2008, in the Gottsegen György Hungarian Institute of Cardiology we performed the first two successful percutaneous aortic valve implantations in Central and Eastern Europe, following a more than one-year preparation period. After seven days the patients were discharged in very good conditions.

AB - Aortic valve replacement can produce dramatic benefit in the setting of symptomatic aortic stenosis. The potential for morbidity and mortality associated with thoracotomy, cardiopulmonary bypass, and aortotomy has fostered a search for alternatives. Early experience with transcatheter endovascular aortic valve implantation demonstrated feasibility and efficacy, but the procedure was difficult to reproduce. However, equipment, techniques, and experience have evolved rapidly. Balloon-expandable and self-expanding prostheses and percutaneous femoral artery and open left ventricular apical access have found favor, each with potential advantages and disadvantages. Procedural success rates and clinical outcomes continue to improve. Current studies suggest that morbidity and mortality rates of percutaneous aortic valve implantations are much better in comparison to conventional surgery in selected high-risk patients. On November 11, 2008, in the Gottsegen György Hungarian Institute of Cardiology we performed the first two successful percutaneous aortic valve implantations in Central and Eastern Europe, following a more than one-year preparation period. After seven days the patients were discharged in very good conditions.

KW - Aortic stenosis

KW - Percutaneous valve interventions

KW - Valve disease

UR - http://www.scopus.com/inward/record.url?scp=64049092687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64049092687&partnerID=8YFLogxK

U2 - 10.1556/OH.2009.28563

DO - 10.1556/OH.2009.28563

M3 - Article

C2 - 19228567

AN - SCOPUS:64049092687

VL - 150

SP - 387

EP - 396

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 9

ER -